Biological E in tech transfer deal to make J&J's vaccine
The Times of India Hyderabad|August 14, 2020
Biological E in tech transfer deal to make J&J's vaccine
Hyderabad: Pharmaceuticals and biologics player Biological E Limited (BE) on Thursday said it has entered into an agreement with Janssen Pharmaceutica NV (Janssen), which is part of Johnson & Johnson (J&J), for manufacturing J&J’s Covid-19 vaccine candidate, Ad26.COV2.S.

As part of the pact, J&J will be transferring the technology for manufacturing its Covid-19 vaccine candidate to Hyderabad-based Bio E.

articleRead

You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber

GoldLogo

Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines

READ THE ENTIRE ISSUE

August 14, 2020